Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

To Study the Safety and Efficacy of Autologous Bone Marrow Stem Cells in Patients With Spinal Cord Injury (SCI)

NCT01730183 is registered in ClinicalTrials.gov with Max Institute of Neurosciences as lead sponsor.

NCT NCT01730183
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01730183 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
To Study the Safety and Efficacy of Autologous Bone Marrow Stem Cells in Patients With Spinal Cord Injury (SCI)
Lead sponsor
Max Institute of Neurosciences
Phase
Phase 1/2
Overall status
Unknown status
Start date
November 30, 2012
Completion date
November 30, 2014
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

spinal cord injury